AU2001284690A1 - Compositions exhibiting synergistic inhibition of the expression and/or activityof cyclooxygenase-2 - Google Patents

Compositions exhibiting synergistic inhibition of the expression and/or activityof cyclooxygenase-2

Info

Publication number
AU2001284690A1
AU2001284690A1 AU2001284690A AU8469001A AU2001284690A1 AU 2001284690 A1 AU2001284690 A1 AU 2001284690A1 AU 2001284690 A AU2001284690 A AU 2001284690A AU 8469001 A AU8469001 A AU 8469001A AU 2001284690 A1 AU2001284690 A1 AU 2001284690A1
Authority
AU
Australia
Prior art keywords
activityof
cyclooxygenase
expression
compositions exhibiting
synergistic inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001284690A
Inventor
John G Babish
Terrence M. Howell
Linda M. Pacioretty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ashni Naturaceuticals Inc
Original Assignee
Ashni Naturaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ashni Naturaceuticals Inc filed Critical Ashni Naturaceuticals Inc
Publication of AU2001284690A1 publication Critical patent/AU2001284690A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
AU2001284690A 2000-08-01 2001-08-01 Compositions exhibiting synergistic inhibition of the expression and/or activityof cyclooxygenase-2 Abandoned AU2001284690A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22219000P 2000-08-01 2000-08-01
US60222190 2000-08-01
US09919510 2001-07-31
US09/919,510 US20020077350A1 (en) 2000-08-01 2001-07-31 Compositions exhibiting synergistic inhibition of the expression and/or activity of clyclooxygenase-2
PCT/US2001/024053 WO2002009698A1 (en) 2000-08-01 2001-08-01 Compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2

Publications (1)

Publication Number Publication Date
AU2001284690A1 true AU2001284690A1 (en) 2002-02-13

Family

ID=26916523

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001284690A Abandoned AU2001284690A1 (en) 2000-08-01 2001-08-01 Compositions exhibiting synergistic inhibition of the expression and/or activityof cyclooxygenase-2

Country Status (3)

Country Link
US (1) US20020077350A1 (en)
AU (1) AU2001284690A1 (en)
WO (1) WO2002009698A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346251B1 (en) * 1999-06-15 2002-02-12 Mark Zamoyski Compositions and methods for treating psoriasis
US6355251B1 (en) * 1999-06-15 2002-03-12 Mark Zamoyski Compositions and methods for epidermal chemexfoliation
US20020076452A1 (en) * 2000-08-01 2002-06-20 Ashni Naturaceuticals, Inc. Combinations of sesquiterpene lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2
JP4680589B2 (en) * 2002-05-31 2011-05-11 ファーマジェネシス， インコーポレイテッド Triptolide derivatives for the regulation of apoptosis and immunosuppression
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040086579A1 (en) * 2002-11-05 2004-05-06 Higgins James W. Dietary supplement comprising parthenolide
US20040247705A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040247706A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal dietary supplement comprising parthenolide
WO2004112819A1 (en) * 2003-06-13 2004-12-29 Gelstat Corporation Compositions and methods of treatment comprising plant extracts
WO2005062913A2 (en) * 2003-12-24 2005-07-14 Pharmagenesis, Inc. Triplide 5,6-derivatives as immunomodulators and anticancer agents
JP5252765B2 (en) * 2003-12-26 2013-07-31 学校法人東京薬科大学 Sebum production inhibitor, sebaceous gland development inhibitor, and skin external preparation
WO2005074953A1 (en) * 2004-02-03 2005-08-18 Universidad Austral De Chile Composition of labdane diterpenes extracted from andrographis paniculata, useful for the treatment of autoimmune diseases, and alzheimer disease by activation of ppr-gamma receptors
EP1722806A4 (en) * 2004-02-09 2009-09-16 Pharmagenesis Inc Methods for isolation of triptolide compounds from tripterygium wilfordii
US7863464B2 (en) * 2004-03-02 2011-01-04 Pharmagenesis, Inc. Triptolide lactone ring derivatives as immunomodulators and anticancer agents
US8617906B2 (en) * 2004-10-13 2013-12-31 Pharmagenesis, Inc. Identification and screening of triptolide target molecules
US8067045B2 (en) * 2005-03-03 2011-11-29 Pharmanex, Llc Nutritional formulations and associated methods
WO2009124264A1 (en) * 2008-04-04 2009-10-08 Metabank System, program product, and method for debit card and checking account autodraw
GB2464813A (en) * 2009-10-23 2010-05-05 Univ Sheffield Treatments for neurodegenerative disorders
FI20106119A0 (en) * 2010-10-27 2010-10-27 Sirtuin Valley Oy A composition for influencing energy metabolism
KR101178947B1 (en) * 2011-04-29 2012-09-03 한국생명공학연구원 A pharmaceutical composition comprising oleanolic acid acetate for preventing or treating TLR and IL-6-mediated diseases
CN102702147B (en) * 2012-06-18 2016-06-08 辽宁利锋科技开发有限公司 The application of andrographolide analog and treatment thereof
DK3510860T3 (en) 2012-08-23 2021-10-18 Senestech Inc Reduction of mammalian reproductive capacity
ITMI20131474A1 (en) * 2013-09-06 2015-03-07 Genesis Bioscience S R L COMPOSITION FOR THE PREVENTION AND TREATMENT OF EMICRANIAN AND NEUROPATHIC PAIN
MX2016010005A (en) * 2014-02-07 2016-10-07 Unilever Nv A topical composition.
US9814670B2 (en) 2014-12-04 2017-11-14 Mary Kay Inc. Cosmetic compositions
US9808011B2 (en) 2014-12-15 2017-11-07 Biovectra Inc. Pentacyclic triterpene compounds and uses thereof
CN105640937B (en) * 2016-01-18 2017-12-22 上海中医药大学 A kind of purposes of dehydrogenation zaluzanin C
CN110785174A (en) * 2017-07-11 2020-02-11 广森医药科技有限公司 Triptolide or compositions comprising triptolide for treating disorders
CA3075023A1 (en) 2017-09-14 2019-03-21 Phoenix Biotechnology, Inc. Method and improved neuroprotective composition for treating neurological conditions
US11331291B2 (en) 2017-09-14 2022-05-17 Phoenix Biotechnology, Inc. Method of and improved composition for treating triterpene-responsive conditions, diseases or disorders
CN110893192B (en) * 2018-09-10 2022-04-29 香港理工大学深圳研究院 Pharmaceutical composition for treating nasopharyngeal carcinoma
CN111704594B (en) * 2020-06-17 2022-05-17 中国科学院昆明植物研究所 Artemisia polyanthrene lactone A-S and Artemisia polyanthrin A-G as well as pharmaceutical composition and application thereof
CN115068467A (en) * 2021-03-15 2022-09-20 中国医学科学院药物研究所 Medical application of andrographolide as LTB4 receptor inhibitor
CN113521061A (en) * 2021-08-17 2021-10-22 张茗涵 Application of traditional Chinese medicine costustoot extract in preparation of medicine for treating pediatric tumors
CN114767694A (en) * 2022-04-12 2022-07-22 温州市人民医院 Application of triptolide in irritable bowel syndrome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962516A (en) * 1997-02-28 1999-10-05 Pharmagenesis, Inc. Immunosuppressive compounds and methods

Also Published As

Publication number Publication date
WO2002009698A1 (en) 2002-02-07
US20020077350A1 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
AU2001284690A1 (en) Compositions exhibiting synergistic inhibition of the expression and/or activityof cyclooxygenase-2
EP1411959A4 (en) Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
IL155196A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
HUP0301178A3 (en) Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same
IL153123A0 (en) N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2001262475A1 (en) Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses
IL158523A0 (en) Epothilone derivatives and pharmaceutical compositions containing the same
IL158044A0 (en) Cyclopropylindole derivatives and pharmaceutical compositions containing the same
WO2000066104A3 (en) Ace-2 inhibiting compounds and methods of use thereof
AU2001244355A1 (en) Heterobiarylsulphonamides and their use as pde 7 inhibitors
IL152846A0 (en) Pyridazinone derivatives and pharmaceutical compositions containing the same
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
HUP0300564A3 (en) Synergistic herbicidal composition and its use
AU5006499A (en) Compositions and methods for the treatment or prevention of pulmonary infections
AU2001275450A1 (en) Bismuth compounds for the treatment and prevention of mucositis
IL159006A0 (en) Phenoxy-phenyl derivatives and pharmaceutical compositions containing the same
AU2002239258A1 (en) Houttuyninum compositions and methods for inhibiting the activity of erbb-2 based thereon
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AUPQ885500A0 (en) Enhancement of products
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications